Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit www.galderma.com
Galderma in Zug, is looking to hire a Global Brand Manager to join our expanding team and manage the RelabotulinumtoxinA (QM-1114) development programme. RelabotulinumtoxinA is a new and innovative toxin developed internally at Galderma, currently undergoing phase 3 clinical studies.